Ophthalmology
Consensus Statement | Management of thyroid eye disease.
12 Dec, 2022 | 12:51h | UTCCommentary: Worldwide Consensus on Thyroid Eye Disease? What Is In a Name? – Thyroid
Cross-sectional study | Subretinal drusenoid deposits are strongly associated with coexistent high-risk vascular diseases.
22 Nov, 2022 | 13:27h | UTCCommentaries:
Specific AMD Phenotypes Strongly Associated with High-Risk Cardiovascular Disease – HCP Live
Subretinal Drusenoid Deposits Linked to High-Risk Vascular Disease in AMD – HealthDay
SR | Early vitrectomy for exogenous endophthalmitis following surgery.
22 Nov, 2022 | 13:20h | UTCEarly vitrectomy for exogenous endophthalmitis following surgery – Cochrane Library
Crossover RCT | Spectacle lenses with highly aspherical lenslets for slowing myopia.
17 Nov, 2022 | 12:16h | UTCRelated:
RCT | The comparison of two different strategies of intravitreal conbercept for polypoidal choroidal vasculopathy.
17 Nov, 2022 | 12:11h | UTCCommentary: Quarterly Dosing of Conbercept Similar to Treat-and-Extend Regimen for PCV – HCP Live
Effective cataract surgical coverage in adults aged 50 years and older: estimates from population-based surveys in 55 countries.
10 Nov, 2022 | 13:32h | UTC
Commentary on Twitter
And Effective cataract surgical coverage in adults aged 50 years and older: estimates from population-based surveys in 55 countries https://t.co/nRMUu2vUI4 (2/2) pic.twitter.com/5E7X2eZtp1
— The Lancet Global Health (@LancetGH) October 13, 2022
Effective refractive error coverage in adults aged 50 years and older: estimates from population-based surveys in 61 countries.
10 Nov, 2022 | 13:31h | UTC
Commentary on Twitter
👀 Two new papers on global eye health: Effective refractive error coverage in adults aged 50 years and older: estimates from population-based surveys in 61 countries https://t.co/ajaICHLySJ (1/2) pic.twitter.com/bPiM8U5Nzb
— The Lancet Global Health (@LancetGH) October 13, 2022
RCT | Effect of text messaging parents of school-aged children on outdoor time to control myopia.
9 Nov, 2022 | 12:26h | UTC
Commentary on Twitter
Using text message reminders to parents offer improved control of #myopia in schoolchildren and should be considered for use with large populations and over large geographic areas. https://t.co/6Dpue8j3Om #Research pic.twitter.com/IMpyGZUQyV
— JAMA Pediatrics (@JAMAPediatrics) September 26, 2022
RCT | Efficacy of an eye-tracking-based dichoptic home treatment for amblyopia.
8 Nov, 2022 | 12:04h | UTC
Recommendations for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis.
3 Nov, 2022 | 14:01h | UTC
SR | Non‐biologic, steroid‐sparing therapies for non‐infectious intermediate, posterior, and panuveitis in adults.
3 Nov, 2022 | 13:40h | UTCSummary: Treatment of inflammatory conditions of the eye with medications – Cochrane Library
Cohort Study | Association of retinal age gap with arterial stiffness and incident cardiovascular disease.
31 Oct, 2022 | 13:32h | UTCAssociation of Retinal Age Gap With Arterial Stiffness and Incident Cardiovascular Disease – Stroke
Related:
Post-hoc analysis | Two-year visual field outcomes of the Treatment for Advanced Glaucoma Study (TAGS).
25 Oct, 2022 | 13:15h | UTCOriginal study and commentary: Study Commentary | Advanced glaucoma: surgery lowers pressure in the eye more effectively than eye drops.
Systematic Review | Topical corticosteroids for dry eye.
24 Oct, 2022 | 14:02h | UTCTopical corticosteroids for dry eye – Cochrane Library
Systematic Review | TNF inhibitors for juvenile idiopathic arthritis‐associated uveitis.
21 Oct, 2022 | 12:55h | UTC
Cohort Study | Association of hyperopia with incident clinically significant depression.
20 Oct, 2022 | 12:18h | UTCCommentary: Older Individuals with Hyperopia More Likely to Develop Incident Depression – HCP Live
Cohort Study | Duration of diabetes and use of insulin are the most important predictors of diabetic retinopathy.
13 Oct, 2022 | 13:44h | UTCCommentary: Insulin Use May Predict the Development of Diabetic Retinopathy – HCP Live
RCT | Topical antibiotics reduce the time to clinical cure in children with infective conjunctivitis.
5 Oct, 2022 | 13:55h | UTCCommentaries:
Topical Antibiotics Shorten Duration of Conjunctival Symptoms – HealthDay
Commentary on Twitter
In this RCT and meta-analysis with 3 prior RCTs, children who received antibiotic eye drops had shorter duration of conjunctivitis vs. placebo. #OAResearch https://t.co/3mq5Fr8NDS
— JAMA Network Open (@JAMANetworkOpen) October 4, 2022
Cohort Study | Artificial intelligence-enabled retinal vasculometry for prediction of cardiovascular diseases.
5 Oct, 2022 | 13:53h | UTCEditorial: The eyes as a window to the heart: looking beyond the horizon – British Journal of Ophthalmology
Commentary: AI eye checks can predict heart disease risk in less than minute, finds study – The Guardian
Related:
RCT | Doxycycline vs. placebo in patients with mild thyroid-associated ophthalmopathy.
30 Sep, 2022 | 12:35h | UTCDoxycycline vs Placebo at 12 Weeks in Patients With Mild Thyroid-Associated Ophthalmopathy: A Randomized Clinical Trial – JAMA Ophthalmology (free for a limited period)
Invited commentary: Oral Doxycycline for Mild Thyroid Eye Disease – JAMA Opthalmology (free for a limited period)
RCT | Cyclosporine A (0.05%) ophthalmic gel in the treatment of dry eye disease.
28 Sep, 2022 | 13:42h | UTC
RCT | 6-year results of primary selective laser trabeculoplasty vs. eye drops for glaucoma and ocular hypertension.
23 Sep, 2022 | 13:06h | UTCOriginal Study: Randomized Trial: Selective Laser Trabeculoplasty vs. Eye Drops for First-line Treatment of Ocular Hypertension and Glaucoma
RCT | Myopia control effect of repeated low-level red-light therapy in children.
20 Sep, 2022 | 13:31h | UTCCommentary: Repeated Low-Level Red-Light Therapy Reduces Myopia Progression in Children – HCP Live
RCT | Patient preference and treatment satisfaction with a port delivery system for Ranibizumab vs. intravitreal injections in patients with neovascular age-related macular degeneration.
30 Aug, 2022 | 12:06h | UTCCommentary: Port Delivery System Preferred Over Intravitreal Injection for Patients with nAMD – HCPLive
Commentary on Twitter
In the phase 3 Archway trial, mean overall treatment satisfaction scores were high in port delivery system & intravitreal injection arms; pts with neovascular AMD preferred treatment via the PDS with ranibizumab vs previous intravitreal injections https://t.co/NYf0aKpKaD
— JAMA Ophthalmology (@JAMAOphth) August 25, 2022
Consensus Recommendations | Diagnosis, management, and treatment of vernal keratoconjunctivitis.
26 Aug, 2022 | 13:21h | UTC